Active Ingredient History
Oolong (, ; simplified Chinese: 乌龙茶; traditional Chinese: 烏龍茶 is a traditional semi-oxidized Chinese tea produced through a process that includes withering the leaves under strong sun and allowing some oxidation to occur before curling and twisting. Most oolong teas, especially those of fine quality, involve unique tea plant cultivars that are exclusively used for particular varieties. The degree of oxidation, which is controlled by the length of time between picking and final drying, can range from 8% to 85% depending on the variety and production style. Oolong is especially popular in southeastern China and among ethnic Chinese in Southeast Asia, as is the Fujian preparation process known as the gongfu tea ceremony. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 2)
Barrett Esophagus (Phase 1)
Blepharitis (Phase 4)
Breast Neoplasms (Phase 2)
Carcinoma, Basal Cell (Phase 2/Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Verrucous (Phase 4)
Cataract (Phase 2/Phase 3)
Colitis, Ulcerative (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Condylomata Acuminata (Phase 4)
COVID-19 (Phase 2)
Diabetes Mellitus (Phase 2/Phase 3)
Diabetes Mellitus, Type 2 (Phase 1/Phase 2)
Doping in Sports (Phase 1)
Dyslipidemias (Phase 3)
Epidermolysis Bullosa Dystrophica (Phase 2)
Esophageal Neoplasms (Phase 3)
Fear (Phase 2/Phase 3)
Fibrosis (Phase 1)
Gingivitis (Phase 3)
Halitosis (Phase 1/Phase 2)
Healthy Volunteers (Phase 2)
HIV Infections (Phase 1)
Hyperlipidemias (Phase 3)
Ichthyosis, Lamellar (Phase 3)
Infections (Phase 2/Phase 3)
Inflammation (Phase 3)
Influenza, Human (Phase 3)
Irritable Bowel Syndrome (Phase 2)
Kidney Failure, Chronic (Phase 2)
Leiomyoma (Phase 3)
Leukemia (Phase 1/Phase 2)
Lichen Planus, Oral (Early Phase 1)
Lung Neoplasms (Phase 3)
Lymphoma, Follicular (Phase 2)
Melanoma (Phase 2)
Metabolic Diseases (Phase 4)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 2)
Neoplasms (Phase 1)
Obesity (Phase 3)
Osteoporosis (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 2)
Overweight (Phase 3)
Papillomavirus Infections (Phase 2)
Pediculus (Phase 4)
Precancerous Conditions (Phase 2)
Prostatic Hyperplasia (Phase 2)
Prostatic Neoplasms (Phase 3)
Respiratory Tract Infections (Phase 2)
SARS-CoV-2 (Phase 3)
Stomach Neoplasms (Phase 3)
Stomatitis (Phase 2)
Tobacco Use Disorder (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Vaginitis (Phase 4)
Warts (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue